CIITA B-cell specific promoter suppression in MHC class II-silenced cell hybrids

Immunogenetics

Volumn 48, Issue 4, 1998, Pages 283-291

  Lennon, Ana Maria ^a   Ottone, Catherine ^a   Rosemblatt, Mario ^b   Fellous, Marc ^a   Bono, Maria Rosa ^b   Alcaïde Loridan, Catherine ^a,c  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF CHILE   (Chile)

^c INSERM   (France)

Author keywords

CIITA; MHC class II; Silencing; Somatic cell hybrid

Indexed keywords

GAMMA INTERFERON; HLA D ANTIGEN; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHROMOSOME SEGREGATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE REPRESSION; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; HYBRID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; B-LYMPHOCYTES; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; HYBRID CELLS; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; SPECIES SPECIFICITY; TRANS-ACTIVATORS;

ANIMALIA;

EID: 0031718872     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050433     Document Type: Article

References (39)

1. Barnstable, C.J., Bodmer, W.F., Brown, G., Galfre, G., Milstein, C., Williams, A.F., and Ziegler, A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell-surface antigens - new tools for genetic analysis. Cell 14:9-20, 1978
2. Bono, M.R., Hyafil, F., Kalil, J., Koblar, V., Wiels, J., Wollman, E., Mawas, C., and Fellous, M. Monoclonal antibodies against HLA-DRw antigens. Transplant Clin Immunol 11: 109-117, 1978
3. Bono, M.R., Benech, P., Couillin, P., Alcaïde-Loridan, C., Grisard, M.C., Jouin, H., Frischer, D.G., and Fellous, M. Characterization of human IFN-γ response using somatic cell hybrids of hematopoietic and nonhematopoietic origin. Somat Cell Mol Cell 15:513-523, 1989
4. Bono, M.R., Alcaïde-Loridan, C., Couillin, P., Letouzé, B., Grisard, M.C., Jouin, H., and Fellous, M. Human chromosome 16 encodes a factor involved in induction of class II major histocompatibility antigens by interferon γ. Proc Natl Acad Sci USA 88:6077-6081, 1991
5. Bontron, S., Steimle, V., Ucla, C., Eibl, M.M., and Mach, B. Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency group A. Hum Genet 99:541-546, 1997
6. Boss, J.M. Regulation of transcription of MHC class II genes. Curr Opin Immunol 9: 107-113, 1997
7. Chang, C.H., Fontes, J.D., Peterlin, M., and Flavell, R.A. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 180: 1367-1374, 1994
8. Chang, C.H. and Flavell, R.A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 181:765-767, 1995
9. Chang, C.H., Guerder, S., Hong, S.C., van Ewijk, W., and Flavell, R.A. Mice lacking the MHC class II Transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4: 167-178, 1996
10. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., and Rutter, W.J. Isolation of biologically-active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979
11. Collins, T., Korman, A.J., Wake, C.T., Boss, J.M., Kappes, D.J., Fiers, W., Ault, A., Grimbrone, M.A., Strominger, J.L., and Pober, P.S. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 81:4917-4921, 1984
12. Dellabona, P., Latron, F., Maffei, A., Scarpellino, L., and Acolla, R.S. Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells. J. Immunol 142:2902-2910, 1989
13. Durand, B., Sperisen, P., Emery, P., Barras, E., Zufferey, M., Mach, B., and Reith, W. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J 16: 1045-1055, 1997
14. 1132. Nucleic Acids Res 25:2522-2528, 1997
15. Germain, R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-299, 1994
16. Glimcher, L.H. and Kara, C.J. Sequences and factors: a guide to MHC class II transcription. Annu Rev Immunol 10: 13-50, 1992
17. Gourdeau, H. and Fournier, R.E.K. Genetic analysis of mammalian cell differentiation. Annu Rev Cell Biol 6:69-94, 1990
18. Halper, J.S., Fu, S.M., Wang, C.Y., Winchester, R., and Kunkel, H.G. Patterns of expression of "Ia-like" antigens during the terminal stages of B cell development. J Immunol 120: 1480-1484, 1978
19. Kappler, J.W., Skidmore, B., White, J., and Marrack, P. Antigen-inducible, H2-restricted, interleukin-2-producing T cell hybridomas. J Exp Med 153: 1198-1214, 1981
20. Kelly, A.P., Monaco, J.J., Cho, S., and Trowsdale, J. A new human HLA class II-related locus, DM. Nature 353:571-573, 1991
21. Latron, F., Jotterand-Bellomo, M., Maffei, A., Scarpellino, L., Bernard, M., Strominger, J.L., and Acolla, R.S. Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc Natl Acad Sci USA 85:2229-2233, 1988
22. Lennon, A.M., Ottone, C., Peijnenburg, A., Hamon-Besnais, C., Colland, F., Gohin, S., van den Elsen, P., Fellous, M., Bono, R., and Alcaïde-Loridan, C. The RAG cell line defines a new complementation group of MHC class II deficiency. Immunogenetics 43:352-359, 1996
23. Lennon, A.M., Ottone, C., Rigaud, G., Deaven, L.L., Longmire, J., Fellous, M., Bono, R., and Alcaïde-Loridan, C. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics 45:266-273, 1997
24. Mach, B., Steimle, V., Martinez-Soria, E., and Reith, W. Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 14:301-331, 1996
25. Mahanta, S.K., Scholl, T., Yang, F.C., and Strominger, J.L. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc Natl Acad Sci USA 94:6324-6329, 1997
26. Muhlethaler-Mottet, A., Otten, L.A., Steimle, V., and Mach, B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by different usage of multiple promoters of the transactivator CIITA. EMBO J 16:2851-2860, 1997
27. Oi, V., Jones, P.P., Coding, J.W., and Herzenberg, L.A. Properties of monoclonal antibodies to mouse Ig allotype, H2 and Ia antigens. Curr Top Microbiol Immunol 81:115-129, 1978
28. Pieters, J. MHC class II restricted antigen presentation. Curr Opin Immunol 9:89-96, 1997
29. Sambrook, J., Fritsch, E.F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, 1989
30. Sartoris, S., Tosi, G., De Lerma Barbaro, A., Cestari, T., and Acolla, R.S. Active suppression of the class II transactivator encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells. Eur J Immmunol 26:2456-2460, 1996
31. Scholl, T., Mahanta, S.K., and Strominger, J.L. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc Natl Acad Sci USA 94:6330-6334, 1997
32. Sellem, C.H., Weiss, M.C., and Cassio, D. Activation of a silent gene is accompanied by its demethylation. J Mol Biol 181: 363-371, 1985
33. Sims, T.N., Elliott, J.F., Ramassar, V., Denney, D.W., and Halloran, P.F. Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivator. Immunogenetics 45:220-222, 1997
34. Southern, P.J. and Berg, P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1:327-341, 1982
35. Sperling, L., Ott, M.O., and Weiss, M.C. Albumin extinction followed by de novo methylation of its gene in somatic hybrids of a rat hepatoma. Biochimie 66:701-710, 1984
36. Steimle, V., Otten, L.A., Zufferey, M., and Mach, B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome). Cell 75:135-146, 1993
37. Steimle, V., Siegrist, C.A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator CIITA. Science 265:106-109, 1994
38. Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M.R., Mach, B., and Reith, W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 9:1021-1032, 1995
39. Stuart, P.M., Yarchover, J.L., and Woodward, J.G. Negative trans-acting factors extinguish Ia expression in B cell-L929 somatic cell hybrids. Cell Immunol 122:391-404, 1989